Micron on Track for Best Monthly Rally Since 1987 Analysts Suggest Further Upside Potential Three African Oil Giants Poised to Benefit From Prolonged Hormuz Strait Disruptions Analysts Suggest Dodgers Will Smith Addresses Health Status After Brief Absence NextEra Energy and Dominion Energy Merger to Create Worlds Largest Electric Utility ADP Reports Private Payrolls Rose 109000 in April Exceeding Forecasts Maxim Group Upgrades Gilead Sciences to Buy Potential Signal of Optimism Core Laboratories Q1 2026 Earnings EPS Misses Estimates as Market Challenges Persist CIEN Q1 2026 Earnings EPS Surprises to the Upside as Stock Rises National Bankshares Inc NKSH Q4 2025 Earnings Strong EPS Beat Amid Steady Operations CANF Q4 2023 Earnings EPS Surprise of 96 as Biotech Reports NarrowerThanExpected Loss EverQuote EVER Q1 2026 Earnings EPS Surprises to the Upside as Stock Gains HLX Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Madrigal Pharmaceuticals MDGL Edges Higher Amid Clinical Progress and Key Technical Levels Redwood Trust Senior Notes RWTP Edge Lower Amid Modest Trading 2439 Support and Resistance Levels in Focus Republic Power Group Limited RPGL Surges 8 as Momentum Builds Around Key Support Solventum SOLV Edges Higher Holds Key Support Amid Cautious Trading Intercont NCT Surges 385 as Shares Approach Key Resistance SP 500 Gains as Healthcare and Tech Outperform Communication Services Lags Alta Equipment Group Q1 2026 Earnings EPS Falls Short of Estimates as Operational Headwinds Persist Quest Diagnostics DGX Slides 12 as Resistance Holds Support in Focus DOCS Q1 2026 Earnings Mixed Results as EPS Misses Estimates but Stock Rises LGL Q1 2026 Earnings Sharp EPS Miss Amidst Minimal Revenue Disclosure Incyte Corp INCY Q1 2026 Earnings Strong EPS Beat Overshadowed by Modest Stock Dip Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings WiderThanExpected Loss as Clinical Pipeline Progresses BNGO Q1 2026 Earnings Narrowing Losses Beat Estimates but Stock Declines on Uncertain Outlook LLY Q1 2026 Earnings Earnings Crush Drives Modest Stock Gains as Revenue Details Remain Limited Voyager Therapeutics Q1 2026 Earnings EPS Beat Masks Strategic Uncertainty as Stock Declines